Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource Telemedicine Enriched Care Model for Autoinflammatory DiseasesJanuary 1, 1970Autoinflammatory diseases arise through inappropriate activation of antigen-independent inflammatory mechanisms and can have a…View Resource Infection or Disease Flare: What Tools Can Help Differentiate?January 1, 1970Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…View Resource JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Polyautoimmunity: axSpA and Familial Mediterranean FeverJanuary 1, 1970Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of…View Resource Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource Anakinra's Effects on COVID-19 OutcomesJanuary 1, 1970Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…View Resource Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
Telemedicine Enriched Care Model for Autoinflammatory DiseasesJanuary 1, 1970Autoinflammatory diseases arise through inappropriate activation of antigen-independent inflammatory mechanisms and can have a…View Resource Infection or Disease Flare: What Tools Can Help Differentiate?January 1, 1970Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…View Resource JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Polyautoimmunity: axSpA and Familial Mediterranean FeverJanuary 1, 1970Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of…View Resource Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource Anakinra's Effects on COVID-19 OutcomesJanuary 1, 1970Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…View Resource Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
Infection or Disease Flare: What Tools Can Help Differentiate?January 1, 1970Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…View Resource JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Polyautoimmunity: axSpA and Familial Mediterranean FeverJanuary 1, 1970Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of…View Resource Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource Anakinra's Effects on COVID-19 OutcomesJanuary 1, 1970Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…View Resource Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Polyautoimmunity: axSpA and Familial Mediterranean FeverJanuary 1, 1970Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of…View Resource Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource Anakinra's Effects on COVID-19 OutcomesJanuary 1, 1970Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…View Resource Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
Polyautoimmunity: axSpA and Familial Mediterranean FeverJanuary 1, 1970Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of…View Resource Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource Anakinra's Effects on COVID-19 OutcomesJanuary 1, 1970Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…View Resource Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource Anakinra's Effects on COVID-19 OutcomesJanuary 1, 1970Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…View Resource Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource Anakinra's Effects on COVID-19 OutcomesJanuary 1, 1970Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…View Resource Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
Anakinra's Effects on COVID-19 OutcomesJanuary 1, 1970Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…View Resource Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
Tocilizumab Risk of Diverticulitis and GI PerforationJanuary 1, 1970A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…View Resource Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource 12345…678
Rhapsody Study: IL-1 Inhibition in Recurrent PericarditisJanuary 1, 1970Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…View Resource